TFAM and cancer: Finally, mtDNA replication stress and injured mitochondria have recently emerged as key drivers of inflammatory responses associated with pathogenic states or cell death by releasing immunostimulatory mtDNA-TFAM fragments, which could be a therapeutic target to improve cancer treatment [80,81].